Kelderman Kim
- SEC CIK
- 0001739054
No open-market purchases or sales filed in the past year.
Current role at each company
- CNMD CONMED CorpDirectoras of Sep 10, 2026
- TECH BIO-TECHNE CorpChief Executive Officeras of Aug 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kelderman Kim as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TECH BIO-TECHNE Corp
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 (view filing) | Jan 27 | 2 days | Kelderman KimChief Executive Officer | SSale | −13.4K | $77.28 | −$1.03M | −25.6%39.0K after | 2 lots |
| Nov 23, 2021 (view filing) | Nov 19 | 4 days | Kelderman KimPres. Diagnostics & Genom | SSale | −500 | $505.38 | −$252.7K | −100.0%0 after | 2 lots |
| Sep 24, 2021 (view filing) | Sep 22 | 2 days | Kelderman KimPres. Diagnostics & Genom | SSale | −822 | $529.04 | −$434.9K | −100.0%0 after |